Medpace Holdings Inc (MEDP) has a current Price-to-Book (P/B) ratio of 55.61. Compared to its 3-year average P/B ratio of 24.48, the current P/B ratio is approximately 127.22% higher. Relative to its 5-year average P/B ratio of 18.78, the current P/B ratio is about 196.11% higher. Medpace Holdings Inc (MEDP) has a Forward Free Cash Flow (FCF) yield of approximately 4.21%. Compared to its 3-year average FCF yield of 4.85%, the current FCF yield is approximately -13.28% lower. Relative to its 5-year average FCF yield of 4.63%, the current FCF yield is about -9.21% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for MEDP competitors is 2.74, providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP.O) exhibits a P/S ratio of 5.80, which is 111.71% above the industry average. Given its robust revenue growth of 32.03%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of MEDP increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of MEDP in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is MEDP currently overvalued or undervalued?

What is Medpace Holdings Inc (MEDP) fair value?

MEDP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Medpace Holdings Inc (MEDP) is between 379.11 to 496.70 according to relative valuation method.

How does MEDP's valuation metrics compare to the industry average?

The average P/S ratio for MEDP's competitors is 2.74, providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP) exhibits a P/S ratio of 5.80, which is 111.71% above the industry average. Given its robust revenue growth of 32.03%, this premium appears sustainable.

What is the current P/B ratio for Medpace Holdings Inc (MEDP) as of Mar 03 2026?

As of Mar 03 2026, Medpace Holdings Inc (MEDP) has a P/B ratio of 55.61. This indicates that the market values MEDP at 55.61 times its book value.

What is the current FCF Yield for Medpace Holdings Inc (MEDP) as of Mar 03 2026?

As of Mar 03 2026, Medpace Holdings Inc (MEDP) has a FCF Yield of 4.21%. This means that for every dollar of Medpace Holdings Inc's market capitalization, the company generates 4.21 cents in free cash flow.

What is the current Forward P/E ratio for Medpace Holdings Inc (MEDP) as of Mar 03 2026?

As of Mar 03 2026, Medpace Holdings Inc (MEDP) has a Forward P/E ratio of 34.74. This means the market is willing to pay $34.74 for every dollar of Medpace Holdings Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Medpace Holdings Inc (MEDP) as of Mar 03 2026?

As of Mar 03 2026, Medpace Holdings Inc (MEDP) has a Forward P/S ratio of 5.80. This means the market is valuing MEDP at $5.80 for every dollar of expected revenue over the next 12 months.

MEDP Valuation